维亚生物 港股通 空最新回购 (2026-06-26) 官网 ( 01873.hk) | 10.53 | 0.58 | 0% | 上市时间2019-05-09股价1.23港币涨跌幅-6.82%成交金额1,418.88万港币换手率0.54%市值25.75亿港币H股市值25.75亿港币总股本20.94亿H股本20.94亿每手股数500上市至今年化投资收益率-16.30%港股通持仓占H股比例8.41% (2.34亿港币2026-07-21) 累计做空占H股比例1.35% (3,414.87万港币2026-07-17) | |||
| 所属三级行业生物技术 (恒生) | 市盈率 | 122.29 | 市净率 | 4.46 | 股息率 | 0.37% | 恒生:医疗保健业药品及生物科技生物技术 |
| 备注 (2): | 双击编辑备注 |
维亚生物(01873) - 历史董事名单
| # | 姓名 | 职衔 | 职位 | 委任日期 | 辞任日期 |
|---|---|---|---|---|---|
| 1 | 吳宇挺 | Non Executive Director | 2022-11-14 | -- | |
| 2 | 孫妍妍 | Non Executive Director | 2020-03-30 | 2022-11-14 | |
| 3 | 毛晨 | Executive Director | Chairman, CEO | 2018-07-03 | -- |
| 4 | 任德林 | Executive Director | 2018-07-03 | -- | |
| 5 | 華風茂 | Executive Director | 2018-07-03 | 2021-06-30 | |
| 6 | 毛隽 | Non Executive Director | 2018-07-03 | 2020-11-03 | |
| 7 | 吳炯 | Non Executive Director | 2018-07-03 | 2020-03-30 | |
| 8 | 傅磊 | Independent Non Executive Director | 2018-04-14 | -- | |
| 9 | 李向榮 | Independent Non Executive Director - A/F | 2018-04-14 | -- | |
| 10 | 王海光 | Independent Non Executive Director | 2018-04-14 | -- | |
| 11 | 吳鷹 | Executive Director | 2009-09-07 | -- |